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A B S T R A C TObjective: The reliability and validity of the European Organization for
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC
QLQ-C30) has not been examined while taking into account the
correlation between subscales. The reliability of the EORTC QLQ-C30
subscales is modest, thus limiting their utility in both clinical and
research settings. The purpose of this study was to validate the factor
structure of multiple-item subscales of the EORTC QLQ-C30 and to
improve their reliability by means of an item response analysis by using
the multidimensional partial credit model. Methods: A total of 2295
patients with complete data were used for the analysis. One- and nine-
dimensional partial credit models were used to ﬁt the data to validate
the construct validity of the multiple-item subscales of the QLQ-C30.
Results: The model comparison showed that the nine-dimensionalsee front matter Copyright & 2013, International S
r Inc.
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.155, Sec. 2, Linong Street, Beitou District, Taipeifactor structure of multiple-item subscales was satisfactory. The multi-
dimensional partial credit model ﬁt data of the multiple-item subscales
of the QLQ-C30 reasonably well. The estimated test reliabilities of each
domain obtained from the multidimensional approach were higher
than those obtained from the unidimensional approach. Conclusions:
The constructs represented by the multiple-item subscales of the QLQ-
C30 were validated. The improved reliability of the multiple-item
subscales of the QLQ-C30 under the multidimensional approach can
facilitate their applications in clinical and research settings.
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Copyright & 2013, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
The European Organization for Research and Treatment of
Cancer’s Quality of Life Questionnaire (EORTC QLQ-C30) was
designed to assess the impact of disease and clinical treatment
on cancer patients’ daily lives [1]. The QLQ-C30 has been trans-
lated into more than 54 languages and is widely used to measure
cancer-speciﬁc quality of life (QOL). A number of studies have
investigated the validity, reliability, and other related measure-
ment properties of the QLQ-C30 [2–7]. The conclusions of these
studies have been that the questionnaire is generally an excellent
QOL instrument, with good psychometric properties relevant to
different cancer-patient populations [2–4,8–11]. However, the
internal consistency, as indicated by Cronbach’s alpha, of some
of the QLQ-C30’s subscales has been found to be poor. For
example, it was reported that Cronbach’s alpha of the
cognitive-function subscale ranged from 0.30 to 0.71 [12–23]. For
the nausea-and-vomiting [NV] subscale, it was only 0.49 [12]. Poor
internal consistency of these subscales can lead to unreliable
evaluations regarding patients’ psychological discomfort [12] andcan mislead clinicians into making incorrect clinical decisions or
inappropriate interpretations of assessment results.
The QLQ-C30 is scored on the basis of classical test theory
(CTT), and uses the total item score as the scale score. In other
words, the main focus of CTT is on test-level information [24].
The correlation between subscales is not taken into consideration
by a CTT analysis when several subscales are analyzed together.
This causes theoretical difﬁculties when CTT is applied to
analyze a scale that consists of several subscales. However, item
response theory, especially the Rasch model, is usually used to
analyze item response data and to provide item-level informa-
tion, regardless of whether it is unidimensional or multidimen-
sional. Through Rasch analysis, the patients’ original ordinal
responses can be transformed into interval scales [25,26]. Within
the interval scale, equal intervals between any two points on a
latent trait are equal in value. Relative to the ordinal scale, the
interval scale can accurately reﬂect the true magnitude of the
difference between repeated assessments and it is more accurate
to show changes over time of a patient or difference between
patients. Therefore, the interval scale can truly reﬂect andociety for Pharmacoeconomics and Outcomes Research (ISPOR).
to this work.
Health Care Administration, School of Medicine, National Yang-
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be analyzed by using parametric statistics, which are often more
powerful than nonparametric methods [28]. Therefore, the Rasch
model is believed to be an objective measurement model and
useful for constructing interval scales [25,29,30].
A multidimensional item response model can improve the
reliability of a measuring instrument that has subscales by taking
into account the correlation among different subscale responses
by the same individual [31]. Besides, because measurement error
is taken into account in the estimation of between-dimensional
correlations in the multidimensional model, the correlation
estimates are then free from the attenuation caused by measure-
ment error [32]. Thus, the multidimensional approach allows a
patient’s responses on subscales to complement one another,
thereby producing a more accurate and reliable assessment of
the patient’s status. This makes it possible to increase the
reliability of each subscale without increasing the number of
items or the physical burden on patients, which is especially
useful for those who are extremely ill [1,33,34].
Although the QLQ-C30 is usually administered as a whole,
subscales of the QLQ-C30 have been used separately and inde-
pendently in clinical studies. For example, three subscales of the
QLQ-C30 (emotional function [EF], social function [SF], and global
health status/quality of life [QL]) were taken as independent
predictors to predict the out- of-hospital length of stay within the
ﬁrst 30 days [35]. In addition, three subscales (pain [PA], NV, and
fatigue [FA]) were scored separately, and they were used to
measure three symptoms that related to cancer patients’ QOL
[36]. As mentioned earlier, however, previous studies have found
poor internal consistency in some of the subscales (e.g., cognitive
function [CF], SF, physical function [PF], role function [RF], NV,
constipation, diarrhea, and PA), which might not only have
threatened the validity of the results of these studies [12–23] but
also hamper the utility of the QLQ-C30 in future studies. The
purpose of the present study was to analyze the responses to the
QLQ-C30 from a sample of cancer patients by using a multidimen-
sional item response model. Speciﬁcally, we examined the
improvement in the results when using the multidimensional
approach compared with using the unidimensional approach
regarding the reliability estimates of the multiple-item subscales.Methods
Subjects
Patients aged 18 years or older and diagnosed with cervical,
breast, lung, liver, or colorectal cancer were recruited through
senior-specialist referrals from the Taipei Veterans General
Hospital, Taichung Veterans General Hospital, Kaohsiung Veter-
ans General Hospital, and the Koo Foundation Sun Yat-sen
Cancer Center from 2003 to 2004. These medical facilities are
located in the northern, central, and southern regions of Taiwan.
The participants were primarily recruited from outpatients who
had received therapy for more than 3 months. Patients with
hepatocellular carcinoma, however, were recruited from among
inpatients. The other selection criterion was the ability to
communicate in Mandarin Chinese or Taiwanese. Patients who
were unaware of their own medical conditions were excluded.
This study was approved by the institutional review boards of all
medical centers involved. All participants gave written informed
consent before participating in the face-to-face interviews.
Procedure
At each of the participating medical facilities, a trained research
nurse interviewed the participants individually in a secluded
interview room after the patient’s routine consultations.Questionnaire
The QLQ-C30 includes nine multiple-item subscales and six
single-item subscales, resulting in 15 domains measured by 30
items [20]. Because latent factors cannot be well deﬁned by a
single item and at least two or three items are recommended [37],
this study focused only on multiple-item subscales. The longest
scale, PF, is measured by ﬁve items, followed by EF and FA, which
are measured by four and three items, respectively. In addition to
the three subscales, 6 of the remaining 12 subscales are meas-
ured by two items. These six are RF, CF, SF, QL, NV, and PA.
Within these subscales, each item has four response categories
—“not at all,” “a little,” “quite a bit,” and “very much”—and are
scored as 1, 2, 3, and 4 in this study, except for the QL subscale, in
which each item is scored from 1 (“very poor”) to 7 (“excellent”).
To rate all subscales in the same direction, the QL subscale was
scored inversely and therefore for all subscales a higher score
indicated a lower QOL.
Data Analysis
Because missing responses for any items in a domain could
produce a large bias in the parameter estimates of the corre-
sponding domain, 205 patients in the sample with missing
observations were excluded from the analysis. A total of 2295
(out of 2500) cancer patients with complete data were included in
the analysis. The data set that comprised multiple-item sub-
scales was analyzed.
The unidimensional and between-item multidimensional
versions of the partial credit model (PCM) were used to ﬁt the
responses for polytomous items in this study. For the unidimen-
sional PCM [38]—an extension of the Rasch model—the subscales
of the QLQ-C30 were analyzed individually, and a set of step
difﬁculties that determine the threshold locations on the latent
continuum should be estimated. This approach requires that
each scale meets the “unidimensionality” assumption; that is,
the scale should measure only one domain. Any other domains
or sources of variation are considered confounding and are not
expected to be included in the PCM analysis because of their
inﬂuence on the accuracy of the estimations.
The between-item multidimensional PCM (MPCM), a special
case of the multidimensional random coefﬁcients multinomial
logit model (MRCMLM) [39], considers responses from several
subscales simultaneously. The MRCMLM is a member of the
family of Rasch models, and it shares the measurement proper-
ties of these models [40]. It allows a general model to be written
that includes most of the existing Rasch models, such as the
unidimensional and multidimensional PCM used in this study.
The equation and parameter explanation of MRCMLM are shown
in Appendix A in Supplemental Materials found at http://dx.doi.
org/10.1016/j.jval.2013.05.004. To address multiple responses
from the same patient, MPCM speciﬁes a correlation structure
between domains in its model formulation. In general, this model
better ﬁts the data than its unidimensional counterpart and
produces parameter estimates that are more accurate [31]. Con-
Quest computer software [41] was used to perform the analysis.
Two models, unidimensional and between-item multidimen-
sional PCM, were ﬁtted to the data, and their overall ﬁts were
compared. Because the two competing models are nested model,
the ﬁt of these two models can be compared with the likelihood
ratio test [42]. The likelihood ratio test statistics, G2, deﬁned as
2loglikelihood, is approximately chi-square distributed with the
degree of freedom equal to the difference between the number of
parameters of two models [43]. The model with smaller deviance,
that is, greater likelihood, would be expected to be closer to the
true model and therefore was selected in this study [44]. Fur-
thermore, the between-dimensional correlations can be esti-
mated with PCM ability estimates, MPCM ability estimates, and
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should be found in the MPCM because measurement error is
taken into account in the estimation of correlations.
Both the PCM and the MPCM were used to analyze the data
and render person separation reliability (PSR), which is used as
the reliability index in this study. Although deﬁned differently,
the PSR is comparable to Cronbach’s alpha in terms of being an
indicator of reliability [45]. The PSR is calculated as indicated
below:
PSR¼1−MSE
SD2
where MSE and SD2 are the sample average measurement error
variance and sample variance in logits, respectively.
In addition, the subscale reliability was calculated by using
both the PCM and the MPCM. The differences in reliability
between the models were compared. The Spearman-Brown for-
mula was used to calculate how many additional items were
needed for each subscale of the QLQ-C30 for the PCM to attain the
same reliability as the MPCM [46,47]. Furthermore, each category
difﬁculty for every item was calculated through adding category
thresholds to the location (mean difﬁculty) parameter to depict
the distribution of category difﬁculties of these multiple-item
subscales, where the item-level information cannot be provided
when analyzing the QLQ-C30 with CTT. Finally, we used the same
analysis procedure for each cancer group to investigate whether
the ﬁndings were consistent across different cancer groups.Table 1 – Participants’ descriptive statistics.
Lung cancer Breast can
n % n %
Sample size 261 435
Age (y), mean  SD (range) 67.2  12.7
(28–92)
48.3  9
(23–86)
Gender
Male 192 73.6 1
Female 68 26.0 434
Marital status
Single 18 6.9 38
Married or with partner 216 82.8 368
Divorced or separated 6 2.3 15
Widowed 21 8.0 14
Education
Primary or below 160 61.3 147
Secondary 47 18.0 122
College or above 51 19.5 161
Subscale scores, mean  SD (range)
Physical functioning 11.00  4.43 (5-20) 7.12  2.12
Role function 4.04  2.10 (2–8) 2.79  1.21
Fatigue 6.36  2.57 (3–12) 5.36  1.80
Emotional functioning 6.63  2.68 (4–16) 6.53  2.40
Pain 3.71  1.72 (2–8) 3.14  1.28
Nausea and vomiting 2.54  1.17 (2–8) 2.53  0.99
Cognitive function 3.40  1.43 (2–8) 3.26  1.16
Social function 3.58  1.87 (2–8) 3.23  1.37
Global health status/quality of life 6.86  2.31 (2–12) 5.78  2.46
Time after diagnosis (mo)
Maximum 248 259
Third quartile 29 45
Median 8 16
First quartile 2 4
Minimum 0 0Results
Descriptive Statistics
A total of 261 (11.4%) patients with lung cancer were included, as
well as 435 (19.0%) with breast cancer, 497 (21.7%) with cervical
cancer, 546 (23.8%) with liver cancer, and 556 (24.2%) with colorectal
cancer. Altogether, this study examined responses from a total of
2295 patients. The clinical and sociodemographic characteristics of
participants and their subscale scores are listed in Table 1.
The ages of patients in the sample ranged from 22 to 93 years.
Among the subgroups of patients, the lowest and highest mean
ages were 48.3 years for patients with breast cancer and 67.2 for
those with lung cancer. Females made up 99.8% of the patients
with breast cancer, whereas 73.6% of the patients with lung cancer,
73.8% of the patients with liver cancer, and 64.6% of the patients
with colorectal cancer were males. As to the subscale scores,
patients with lung cancer and cervical cancer got the highest and
the lowest scores, respectively, across all subscales except for the
PF and QL subscales. Additional details are provided in Table 1.Model-Data Fit
Table 2 shows the values for the deviance, number of parameters,
and likelihood ratio test of the unidimensional and nine-
dimensional models. The nine-dimensional model had acer Cervical
cancer
Liver cancer Colorectal
cancer
n % n % n %
497 546 556
.8 56.1  11.9
(26–87)
63.8  12.8
(26–93)
64.9  12.6
(22–89)
0.2 0 0 403 73.8 359 64.6
99.8 497 100 143 26.2 193 34.7
8.7 8 1.6 25 4.6 13 2.3
84.6 342 68.8 471 86.2 464 83.5
3.4 41 8.2 20 3.7 13 2.3
3.2 106 21.3 29 5.3 66 11.9
33.8 376 75.7 368 67.4 289 52.0
28.1 81 16.3 103 18.8 124 22.3
37.0 28 5.6 73 13.4 142 25.5
(5-17) 7.13  2.46 (5–20) 9.64 3.96 (5–20) 8.76  3.74 (5–20)
(2–8) 2.55  1.27 (2–8) 3.54  1.85 (2–8) 3.29  1.98 (2–8)
(3-12) 4.53  1.75 (3–12) 6.12 2.40 (3–12) 5.40  2.50 (3–12)
(4-16) 5.87  2.29 (4–16) 6.47 2.68 (4–16) 6.07  2.68 (4–16)
(2–8) 2.96  1.27 (2–8) 3.36  1.46 (2–8) 3.06  1.51 (2–8)
(2–8) 2.15  0.54 (2–6) 2.42  0.91 (2–7) 2.32  0.99 (2–8)
(2–8) 3.04  1.15 (2–8) 3.12  1.09 (2–8) 3.04  1.23 (2–8)
(2–8) 2.54  1.07 (2–8) 3.55  1.52 (2–8) 2.89  1.56 (2–8)
(2-14) 5.93  2.08 (2–14) 7.38 2.31 (2–14) 5.44  2.27 (2–14)
300 246 300
90 33 41.8
51.5 9 17
21 1 5
0 0 0
Table 2 – Likelihood ratio test of two models for the
multiple-item subscale of the QLQ-C30.
Model Deviance Number of
parameters
Likelihood
ratio
Unidimensional 95297.46 79
Nine-dimensional 87688.09 123 7609.37
QLQ-C30, European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire.
 Pðχ2df¼44468:71Þo0:001:
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The change in deviance from the unidimensional model to the
nine-dimensional model was statistically signiﬁcant (P o 0.001).
After the factor structure was identiﬁed, the between-
dimensional correlations were calculated and are listed in
Table 3. Correlations above and below the diagonal were calcu-
lated with the PCM and the MPCM, respectively, whereas corre-
lations in parentheses were calculated with raw scores. After
scoring all subscales in the same direction, the correlations
between the nine subscales ranged from 0.42 to 0.91 when
calculated with the MPCM. These results showed that moderate
to high correlations existed between subscales of the QLQ-C30.
The results also showed that between-dimensional correlations
were higher under MPCM estimates, whereas correlations that
were calculated with PCM estimates were close to those esti-
mated with raw scores. This is because both undimensional PCM
estimates and raw scores did not take the measurement error
into account when estimating between-dimensional correlations
and therefore caused correlation attenuation [32].
Reliability
Subscale reliabilities analyzed by the PCM and the MPCM are
listed in Table 4. Reliabilities of subscales ranged from 0.47 to 0.89
when the data were analyzed with the PCM. Reliabilities of only
the PF, FA, and QL subscales were greater than or equal to 0.80,
whereas reliabilities for the CF and NV subscales were found to be
lower than 0.50. When using the MPCM, reliabilities increased
and ranged from 0.66 to 0.90, indicating moderate to acceptable
reliabilities. In general, reliabilities based on the multidimen-
sional model were higher than those obtainable with the
unidimensional model.
To express the difference between the two models in a more
concrete manner, the difference in reliability was furtherTable 3 – The correlations between the nine subscales o
PF RF EF CF
PF 1.00 .68 (.75) .32 (.34) .37 (.39) .42
RF .91 1.00 .34 (.35) .36 (.38) .48
EF .80 .81 1.00 .46 (.47) .41
CF .84 .79 .86 1.00 .35
SF .52 .59 .69 .75
QL .42 .48 .67 .68
FA .62 .62 .75 .74
NV .63 .73 .74 .74
PA .58 .58 .73 .61
Notes. Correlations above the diagonal were calculated with the PCM;
correlations in parentheses were calculated with raw score.
CF, cognitive function; EF, emotional function; FA, fatigue; MPCM, multid
PCM, partial credit model; PF, physical function; QL, global health/quality
of Cancer Quality of Life Questionnaire; RF, role function; SF, social functransformed into a difference-in-test length by using the
Spearman-Brown formula. For example, to increase the reliability
of the PF subscale from 0.80 (under the PCM) to 0.89 (under the
MPCM), an additional ﬁve items are required and the test length
should be increased from 5 to 10. Similarly, test lengths should be
increased by adding three (100%) and two items (50%) into the FA
and EF subscales, respectively. The number of items needed to be
added and the original test length for each subscale are listed in
Table 4.
Item Analysis
The step difﬁculties of all items in the nine multiple-item
subscales are listed in Table 5. Except for the former two four
steps of the QL subscale and the ﬁrst step of items 1, 2, 10, 12, 18,
and 25, all other step difﬁculties of the subscales were positive,
which means that these items were moderately to highly difﬁcult
for the patients. In other words, patients tended to get lower
scores in these items and showed better quality in their life. For
the QL subscale, after being scored in the same direction as the
other eight subscales, the ﬁrst two step difﬁculties for both items
were negative, which means that patients tended to get low to
moderate score on the QL subscale.
Table 6 lists raw scores of each subscale for four randomly
selected patients. The patients with the same raw score had
identical ability estimates under the PCM, but not for the MPCM.
For example, patients 2 and 3 had identical raw scores in PF, RF,
CF, QL, NV, and PA, and they got the same PCM ability estimates
in these subscales. Patient 3, however, had higher raw scores in
the other three subscales of EF, SF, and FA, and he/she got higher
MPCM ability estimates in all subscales. This is because all
subscales were positively correlated, and this effect had been
taken into account in the estimation procedure. These examples
show the advantages of the MPCM in producing reliable esti-
mates that cannot be achieved by the PCM or the CTT.Discussion
Model-Data Fit and Construct Validity
The purpose of this study was to validate the factor structures of
multiple-item subscales of the EORTC QLQ-C30 and to improve
their reliability by means of an item response analysis by using the
between-item MPCM model. We found a statistically signiﬁcant
(P o 0.001) change in deviance from the unidimensional model to
the nine-dimensional model, indicating a better ﬁt between thef the QLQ-C30.
SF QL FA NV PA
(.46) .47 (.47) .64 (.67) .26 (.28) .50 (.54)
(.50) .44 (.43) .60 (.63) .28 (.29) .51 (.55)
(.42) .35 (.34) .47 (.48) .26 (.27) .40 (.40)
(.37) .35 (.36) .45 (.46) .26 (.29) .42 (.45)
1.00 .42 (.42) .49 (.52) .31 (.33) .42 (.45)
.48 1.00 .49 (.50) .28 (.29) .45 (.46)
.71 .83 1.00 .37 (.38) .57 (.60)
.63 .63 .66 1.00 .31 (.34)
.47 .46 .54 .60 1.00
correlations below the diagonal were calculated with the MPCM;
imensional partial credit model; NV, nausea-and-vomiting; PA, pain;
of life; QLQ-C30, European Organization for Research and Treatment
tion.
Table 4 – The reliabilities of both models for the multiple-item subscales of the QLQ-C30.
PF RF EF CF SF QL FA NV PA
Test length 5 2 4 2 2 2 3 2 2
PCM .80 .72 .75 .47 .71 .89 .80 .47 .71
MPCM .89 .88 .83 .80 .78 .90 .89 .66 .84
Items to be added to reach the reliability
estimated by the MPCM
5 4 2 7 1 1 3 3 3
CF, cognitive function; EF, emotional function; FA, fatigue; MPCM, multidimensional partial credit model; NV, nausea-and-vomiting; PA, pain;
PCM, partial credit model; PF, physical function; QL, global health/quality of life; QLQ-C30, European Organization for Research and Treatment
of Cancer Quality of Life Questionnaire; RF, role function, SF, social function.
 Estimated by using the Spearman-Brown formula.
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validity of the QLQ-C30. Through MPCM analysis, the patients’
original responses can be transformed into interval scales [25,26],
and the true magnitude of the difference between repeated
assessments, changes over time of a patient, or difference between
patients can be accurately reﬂected [27]. The examples listed in
Table 6 also showed the advantage of the MPCM in producing
accurate estimates that cannot be achieved by the PCM or the CTT.
In this study, we focused simultaneously on the construct
validity of several subscales for patients with different cancers
rather than on a single subscale for patients with a speciﬁc cancer.
According to the goodness-of-ﬁt indices, the multidimensionalTable 5 – The step difﬁculties of every item of multiple-i
Step 1 Step 2 Ste
Physical function (PF)
Item 1 1.07 0.26 1.
Item 2 0.14 0.87 1.
Item 3 1.89 2.34 3.
Item 4 0.74 2.30 3.
Item 5 2.80 3.12 3.
Role function (RF)
Item 6 1.09 3.64 5.
Item 7 0.94 3.76 5.
Fatigue (FA)
Item 10 0.98 1.99 4.
Item 12 0.21 2.14 4.
Item 18 0.84 2.08 4.
Emotional function (EF)
Item 21 0.65 2.60 4.
Item 22 0.39 2.46 4.
Item 23 0.91 2.99 4.
Item 24 0.42 2.75 3.
Pain (PA)
Item 9 0.04 2.21 3.
Item 19 0.77 2.31 3.
Nausea and vomiting (NV)
Item 14 2.37 3.53 4.
Item 15 2.87 3.60 5.
Cognitive function (CF)
Item 20 1.15 2.26 2.
Item 25 0.22 1.83 2.
Social function (SF)
Item 26 0.62 3.10 4.
Item 27 0.81 2.87 4.
Global quality of life (QL)
Item 29 5.46 1.78 1.
Item 30 5.09 1.70 1.
NA, not applicable; QLQ-C30, European Organization for Research and Tmodel ﬁtted the responses better than the unidimensional model
for both overall and subgroup analyses (subgroup results are
shown in Appendix B in Supplemental Materials found at http://
dx.doi.org/10.1016/j.jval.2013.05.004.). This ﬁnding provides empiri
cal evidence that we should consider the QLQ-C30 as a multidimen
sional scale to accurately measure the multiple QOL domains of
patients, which is what the QLQ-C30 is supposed to measure [3–6].
Reliability
The reliability of the subscales was higher when the data were
analyzed with the MPCM than with the PCM. This is becausetem subscales of the QLQ-C30.
p 3 Step 4 Step 5 Step 6
03 NA NA NA
76 NA NA NA
22 NA NA NA
17 NA NA NA
29 NA NA NA
35 NA NA NA
38 NA NA NA
17 NA NA NA
10 NA NA NA
07 NA NA NA
16 NA NA NA
00 NA NA NA
55 NA NA NA
97 NA NA NA
64 NA NA NA
15 NA NA NA
81 NA NA NA
04 NA NA NA
69 NA NA NA
97 NA NA NA
27 NA NA NA
11 NA NA NA
15 3.76 6.21 7.29
24 3.76 6.19 7.04
reatment of Cancer Quality of Life Questionnaire.
Table 6 – Raw scores, PCM, and MPCM ability estimates for four randomly selected patients.
Patient ID PF RF EF CF SF QL FA NV PA
Raw score
1 7 2 7 2 3 3 5 2 2
2 5 2 4 2 2 2 3 2 2
3 5 2 5 2 4 2 5 2 2
4 6 2 6 3 4 2 4 3 3
PCM estimates
1 0.42 6.71 1.14 0.88 1.02 6.44 0.12 1.76 2.65
2 2.54 6.71 2.30 0.88 3.08 9.64 3.41 1.76 2.65
3 2.54 6.71 0.59 0.88 2.92 9.64 0.12 1.76 2.65
4 1.25 6.71 0.42 0.03 2.92 9.64 1.42 5.52 0.37
MPCM estimates
1 0.88 1.87 1.10 0.61 0.47 0.50 0.16 0.59 4.15
2 3.92 7.59 3.48 4.82 2.25 3.44 2.05 2.75 7.51
3 1.96 2.77 1.53 1.21 0.48 0.69 0.47 0.63 5.54
4 1.61 1.59 0.77 0.89 0.00 0.32 0.06 0.21 5.43
CF, cognitive function; EF, emotional function; FA, fatigue; MPCM, multidimensional partial credit model; NV, nausea-and-vomiting; PA, pain;
PCM, partial credit model; QL, global health/quality of life; PF, physical function; QLQ-C30, European Organization for Research and Treatment
of Cancer Quality of Life Questionnaire; RF, role function; SF, social function.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 8 4 8 – 8 5 4 853when the MPCM was used, the correlation between the domains
was taken into consideration [48–51]. For example, when a
patient was able to correctly answer an item designed to measure
the PF domain, this direct information was helpful for estimating
the patient’s ability on the PF domain. At the same time, indirect
information was provided by estimating the patient’s abilities in
both the RF and EF domains by means of the association between
PF and RF (r ¼ 0.91) and the association between PF and EF (r ¼
0.80). For subscales of the QLQ-C30 that consisted of two or more
items, better reliability in estimating the ability of each domain
can be attained by using the correlations between subscales
calculated by the MPCM. Therefore, by analyzing the data with
the MPCM, more reliable QOL information can be achieved.
To illustrate the implication of the improvement in reliability
from the PCM to the MPCM, we calculated the subscale lengths
required under the PCM to reach the equivalent reliabilities under
the MPCM. One to seven additional items were required for these
multiple-item subscales. After adding these items, the subscale
reliability increments ranged from 0.01 to 0.33, with the average
increment over nine subscales equaling 0.13. Therefore, it can be
concluded that the advantage of analyzing the QLQ-C30 data by
using the MPCM is that it increases the reliability of the scale
without having to increase the test length and consequently not
augmenting the burden of the test for both the clinicians and the
patient. In addition, increasing the test length to yield higher
reliability is challenging for researchers because it can be difﬁcult
to generate an additional set of good items.Limitations
The utility of our ﬁndings may be limited because the MPCM
scores can be obtained only via a parameter-estimation proce-
dure, rather than by just summating the item scores for each
subscale. Our standalone program could be useful to prospective
users of our method. For users who want to analyze data with the
MPCM, patients’ responses on every item should be recorded as a
text ﬁle and then run the analysis with our standalone program
(which is available on request). After the analysis, patients’ scores
on the QLQ-C30 subscales would be ranging from roughly 6 to 6
(except for the QL subscale, for which it ranges from 8 to 8),
where higher values represent a lower level of QOL in the
corresponding domain. In the future, computerized adaptive
testing (CAT) could be developed on the basis of our ﬁndings.Although the development of CAT is complex, the related testing
is efﬁcient as can be the output [52]. The advantages of CAT could
signiﬁcantly improve the efﬁciency of both patient and data
management.
Eight percent of the patients were removed from analysis
because of missing responses. The excluded patients were older
than those included in the current study (exact results are
available on request). Therefore, the results of analysis might
have been biased.Conclusions
The construct validity of the nine-subscale subset of the multi-
item QLQ-C30 subscale was conﬁrmed in the current study. The
attainable values of reliability for the subscales of the QLQ-C30
were higher when using the MPCM than when using the unidi-
mensional approach. The multidimensional approach is recom-
mended so that responses to the QLQ-C30 can be more reliably
measured without having to append new test items to the
existing scale. The ﬁndings of this study should be validated in
other countries to verify that the multidimensional model was
able to increase the reliability of most QLQ-C30 subscales.
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